U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07180420) titled 'Proof of Concept (PoC) Evaluation of Naloxone Unique Intramuscular (IM) Injection' on Sept. 05.
Brief Summary: WHAT IS THE PURPOSE OF THIS RESEARCH STUDY
This research study is designed to demonstrate that intramuscular (IM) Injection of FDA Approved Naloxone Hydrochloride (HCI) given in the forearm muscle is approximately the same as given the injection in the buttocks muscle. STAT Therapeutics Inc. is sponsoring this research study.
BACKGOUND AND PURPOSE FOR THIS STUDY
You are being asked to participate in this research study because you are between the ages of 18 and 55 and appear to be in stable health. Naloxone HCI is FDA a...